CONTACT US Tell us your raw material and project budget to get quotations within 24 hours
This documentation must come from the prescribing provider and typically needs to specify the clinical reason for compounding, such as: Allergy to an inactive ingredient in the commercial product Need for a dose not available in commercial presentations Documented intolerance to the commercial delivery device Billing compounded tirzepatide through the pharmacy benefit uses standard pharmacy claim formats (NCPDP) with the compounding pharmacy NDC
For individuals experiencing chronic fatigue or low energy, evaluating B12 deficiency can be a crucial step
Who is a Candidate for BPC-157
503A compounded research compound Primary CV mechanism / Upregulation of eNOS and VEGFR2, leading to increased nitric oxide production Arrhythmia data / Attenuated QTc prolongation and ventricular arrhythmias in rat dopamine-toxicity models Blood pressure data / Dose-dependent reduction of systolic BP in hypertensive rat models
However, because this product provides doses far above the daily nutritional requirements (for instance 100 mg of B vs an RDA of ~1.4 mg), its use in pregnancy must be carefully considered